Cannabinoids in medicine: A review of their therapeutic potential

Amar, Mohamed Ben

doi:10.1016/j.jep.2006.02.001

Cited by 422 publications

(219 citation statements)

References 121 publications

Supporting

Mentioning

196

Contrasting

Unclassified

Order By: Relevance

“…Recently, control regimes for cannabis as a psychoactive substance have diversified considerably in North American jurisdictions, from mainly prohibitive to more liberal control systems, including legal regimes, where cannabis is legally accessible for therapeutic purposes [3,4]. Therapeutic benefits from cannabis have been suggested for numerous, usually chronic, health conditions, yet are most strongly evidenced primarily for neuropathic pain, spasticity, as well as anti-emetic and appetite-stimulant effects (e.g., for “wasting syndrome”) [5,6,7,8]. Medical cannabis control regimes exist in numerous US states and Canada (since 2001), among other countries [3,4,9].…”

Section: Introductionmentioning

confidence: 99%

Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics

et al. 2017

View full text Add to dashboard Cite

Background: While recreational cannabis use is common, medical cannabis programs have proliferated across North America, including a federal program in Canada. Few comparisons of medical and recreational cannabis users (RCUs) exist; this study compared these groups on key characteristics. Methods: Data came from a community-recruited sample of formally approved medical cannabis users (MCUs; n = 53), and a sub-sample of recreational cannabis users (RCUs; n = 169) from a representative adult survey in Ontario (Canada). Samples were telephone-surveyed on identical measures, including select socio-demographic, substance and medication use, and health and disability measures. Based on initial bivariate comparisons, multivariate logistical regression with a progressive adjustment approach was performed to assess independent predictors of group status. Results: In bivariate analyses, older age, lower household income, lower alcohol use, higher cocaine, prescription opioid, depression and anxiety medication use, and lower health and disability status were significantly associated with medical cannabis use. In the multivariate analysis, final model, household income, alcohol use, and disability levels were associated with medical cannabis use. Conclusions/Scientific Significance: Compared to RCUs, medical users appear to be mainly characterized by factors negatively influencing their overall health status. Future studies should investigate the actual impact and net benefits of medical cannabis use on these health problems.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics

et al. 2017

View full text Add to dashboard Cite

show abstract

“…El dronabinol también tiene como indicación el síndrome de anorexia-caquexia en el contexto de cáncer terminal o del SIDA. Cabe destacar que algunos de los agonistas sintéticos (CT-3, el dexanabinol o el WIN 55212-2, entre otros), se han evaluado o están siendo evaluados en humanos para patologías diversas, fundamentalmente neurológicas y en el dolor 22 .…”

Section: Endocanabinoides (Eicosanoides)unclassified

Spice drugs: los cannabinoides como nuevas drogas de diseño

et al. 2009

View full text Add to dashboard Cite

“…It is one of the oldest naturally psychoactive substances known to humans and grows naturally in many countries. 1,2 Although marijuana has been used for both medicinally and recreationally throughout the world for thousands of years, 1 it still remains illegal to grow, use and possess in most countries, including Canada, 3 which has been illegal since 1923. Although it is illegal to use marijuana for recreational purposes, its use as a potential therapy is legal and deemed appropriate by the Supreme Court of Canada since July 30, 2001.…”

Section: Introductionmentioning

confidence: 99%

Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts

Hajizadeh

2016

Int J Health Policy Manag

View full text Add to dashboard Cite

Notwithstanding a century of prohibition, marijuana is the most widely used illicit substance in Canada. Due to the growing public acceptance of recreational marijuana use and ineffectiveness of the existing control system in Canada, the issue surrounding legalizing this illicit drug has received considerable public and political attentions in recent years. Consequently, the newly elected Liberal Government has formally announced that Canada will introduce legislation in the spring of 2017 to start legalizing and regulating marijuana. This editorial aims to provide a brief overview on potential economic, social, and public health impacts of legal marijuana in Canada. The legalization could increase tax revenue through the taxation levied on marijuana products and could also allow the Government to save citizens' tax dollars currently being spent on prohibition enforcement. Moreover, legalization could also remove the criminal element from marijuana market and reduce the size of Canada's black market and its consequences for the society. Nevertheless, it may also lead to some public health problems, including increasing in the uptake of the drug, accidents and injuries. The legalization should be accompanied with comprehensive strategies to keep the drug out of the hands of minors while increasing awareness and knowledge on harmful effects of the drug. In order to get better insights on how to develop an appropriate framework to legalize marijuana, Canada should closely watch the development in the neighboring country, the United States, where some of its states viz, Colorado, Oregon, Washington, and Alaska have already legalized recreational use of marijuana.

show abstract

Cannabinoids in medicine: A review of their therapeutic potential

Cited by 422 publications

References 121 publications

Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics

Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics

Spice drugs: los cannabinoides como nuevas drogas de diseño

Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts

Contact Info

Product

Resources

About